Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes

Abstract Malaria parasite transmission to mosquitoes relies on the uptake of sexual stage parasites during a blood meal and subsequent formation of oocysts on the mosquito midgut wall. Transmission-blocking vaccines (TBVs) and monoclonal antibodies (mAbs) target sexual stage antigens to interrupt hu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Roos M. de Jong, Lisette Meerstein-Kessel, Dari F. Da, Sandrine Nsango, Joseph D. Challenger, Marga van de Vegte-Bolmer, Geert-Jan van Gemert, Elias Duarte, Noam Teyssier, Robert W. Sauerwein, Thomas S. Churcher, Roch K. Dabire, Isabelle Morlais, Emily Locke, Martijn A. Huynen, Teun Bousema, Matthijs M. Jore
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/852c3163e8664f10865e9f61f43db532
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:852c3163e8664f10865e9f61f43db532
record_format dspace
spelling oai:doaj.org-article:852c3163e8664f10865e9f61f43db5322021-12-02T18:50:54ZMonoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes10.1038/s41541-021-00366-92059-0105https://doaj.org/article/852c3163e8664f10865e9f61f43db5322021-08-01T00:00:00Zhttps://doi.org/10.1038/s41541-021-00366-9https://doaj.org/toc/2059-0105Abstract Malaria parasite transmission to mosquitoes relies on the uptake of sexual stage parasites during a blood meal and subsequent formation of oocysts on the mosquito midgut wall. Transmission-blocking vaccines (TBVs) and monoclonal antibodies (mAbs) target sexual stage antigens to interrupt human-to-mosquito transmission and may form important tools for malaria elimination. Although most epitopes of these antigens are considered highly conserved, little is known about the impact of natural genetic diversity on the functional activity of transmission-blocking antibodies. Here we measured the efficacy of three mAbs against leading TBV candidates (Pfs48/45, Pfs25 and Pfs230) in transmission assays with parasites from naturally infected donors compared to their efficacy against the strain they were raised against (NF54). Transmission-reducing activity (TRA) was measured as reduction in mean oocyst intensity. mAb 45.1 (α-Pfs48/45) and mAb 4B7 (α-Pfs25) reduced transmission of field parasites from almost all donors with IC80 values similar to NF54. Sequencing of oocysts that survived high mAb concentrations did not suggest enrichment of escape genotypes. mAb 2A2 (α-Pfs230) only reduced transmission of parasites from a minority of the donors, suggesting that it targets a non-conserved epitope. Using six laboratory-adapted strains, we revealed that mutations in one Pfs230 domain correlate with mAb gamete surface binding and functional TRA. Our findings demonstrate that, despite the conserved nature of sexual stage antigens, minor sequence variation can significantly impact the efficacy of transmission-blocking mAbs. Since mAb 45.1 shows high potency against genetically diverse strains, our findings support its further clinical development and may inform Pfs48/45 vaccine design.Roos M. de JongLisette Meerstein-KesselDari F. DaSandrine NsangoJoseph D. ChallengerMarga van de Vegte-BolmerGeert-Jan van GemertElias DuarteNoam TeyssierRobert W. SauerweinThomas S. ChurcherRoch K. DabireIsabelle MorlaisEmily LockeMartijn A. HuynenTeun BousemaMatthijs M. JoreNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Roos M. de Jong
Lisette Meerstein-Kessel
Dari F. Da
Sandrine Nsango
Joseph D. Challenger
Marga van de Vegte-Bolmer
Geert-Jan van Gemert
Elias Duarte
Noam Teyssier
Robert W. Sauerwein
Thomas S. Churcher
Roch K. Dabire
Isabelle Morlais
Emily Locke
Martijn A. Huynen
Teun Bousema
Matthijs M. Jore
Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
description Abstract Malaria parasite transmission to mosquitoes relies on the uptake of sexual stage parasites during a blood meal and subsequent formation of oocysts on the mosquito midgut wall. Transmission-blocking vaccines (TBVs) and monoclonal antibodies (mAbs) target sexual stage antigens to interrupt human-to-mosquito transmission and may form important tools for malaria elimination. Although most epitopes of these antigens are considered highly conserved, little is known about the impact of natural genetic diversity on the functional activity of transmission-blocking antibodies. Here we measured the efficacy of three mAbs against leading TBV candidates (Pfs48/45, Pfs25 and Pfs230) in transmission assays with parasites from naturally infected donors compared to their efficacy against the strain they were raised against (NF54). Transmission-reducing activity (TRA) was measured as reduction in mean oocyst intensity. mAb 45.1 (α-Pfs48/45) and mAb 4B7 (α-Pfs25) reduced transmission of field parasites from almost all donors with IC80 values similar to NF54. Sequencing of oocysts that survived high mAb concentrations did not suggest enrichment of escape genotypes. mAb 2A2 (α-Pfs230) only reduced transmission of parasites from a minority of the donors, suggesting that it targets a non-conserved epitope. Using six laboratory-adapted strains, we revealed that mutations in one Pfs230 domain correlate with mAb gamete surface binding and functional TRA. Our findings demonstrate that, despite the conserved nature of sexual stage antigens, minor sequence variation can significantly impact the efficacy of transmission-blocking mAbs. Since mAb 45.1 shows high potency against genetically diverse strains, our findings support its further clinical development and may inform Pfs48/45 vaccine design.
format article
author Roos M. de Jong
Lisette Meerstein-Kessel
Dari F. Da
Sandrine Nsango
Joseph D. Challenger
Marga van de Vegte-Bolmer
Geert-Jan van Gemert
Elias Duarte
Noam Teyssier
Robert W. Sauerwein
Thomas S. Churcher
Roch K. Dabire
Isabelle Morlais
Emily Locke
Martijn A. Huynen
Teun Bousema
Matthijs M. Jore
author_facet Roos M. de Jong
Lisette Meerstein-Kessel
Dari F. Da
Sandrine Nsango
Joseph D. Challenger
Marga van de Vegte-Bolmer
Geert-Jan van Gemert
Elias Duarte
Noam Teyssier
Robert W. Sauerwein
Thomas S. Churcher
Roch K. Dabire
Isabelle Morlais
Emily Locke
Martijn A. Huynen
Teun Bousema
Matthijs M. Jore
author_sort Roos M. de Jong
title Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
title_short Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
title_full Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
title_fullStr Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
title_full_unstemmed Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoes
title_sort monoclonal antibodies block transmission of genetically diverse plasmodium falciparum strains to mosquitoes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/852c3163e8664f10865e9f61f43db532
work_keys_str_mv AT roosmdejong monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT lisettemeersteinkessel monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT darifda monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT sandrinensango monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT josephdchallenger monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT margavandevegtebolmer monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT geertjanvangemert monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT eliasduarte monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT noamteyssier monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT robertwsauerwein monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT thomasschurcher monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT rochkdabire monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT isabellemorlais monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT emilylocke monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT martijnahuynen monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT teunbousema monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
AT matthijsmjore monoclonalantibodiesblocktransmissionofgeneticallydiverseplasmodiumfalciparumstrainstomosquitoes
_version_ 1718377516064833536